Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

Regeneron Pharmaceuticals

manufacturer

70/100

Regeneron Pharmaceuticals is a manufacturer that makes prescription drugs. pharmaranks independently rates 6 of its products, with a composite rating of 3.5 out of 5 based on FDA regulatory (recall-safety) data.

Rated against independent sources·Last updated August 21, 2026·How we rate

Products (6)

Rx70/100

dupixent

Dupilumab

(1 data points)
Price variesView
Rx70/100

evkeeza

Evinacumab-Dgnb

(1 data points)
Price variesView
Rx70/100

eylea hd

Aflibercept

(1 data points)
Price variesView
Rx70/100

inmazeb

Atoltivimab and Odesivimab and Maftivimab

(1 data points)
Price variesView
Rx70/100

praluent

Alirocumab

(1 data points)
Price variesView
Rx70/100

veopoz

Pozelimab-Bbfg

(1 data points)
Price variesView

Reviews

No reviews yet. Be the first to write one.

Write a review

Reviews are user opinions, not medical advice. Consult a licensed professional.

Frequently asked questions

What does Regeneron Pharmaceuticals make?

Regeneron Pharmaceuticals makes prescription drugs. pharmaranks independently rates 6 of its products — see the full list below.

How is Regeneron Pharmaceuticals rated?

pharmaranks gives Regeneron Pharmaceuticals a composite rating of 3.5 out of 5, based on FDA regulatory (recall-safety) data across its products. See the source breakdown on this page.